提问
问诊
发现
计算
注册
注册
登录
登录
发现
FDA Approval of Gazyva (Obinutuzumab) for Active Lupus Nephritis: Superiority Over Standard Therapy Demonstrated in Phase III REGENCY Trial - Vera Health News